Search results
Pfizer, looking for a jumpstart, leans into cancer drug research
BioPharma Dive via Yahoo Finance· 4 months agoPfizer believes the answer to its sliding valuation lies in oncology. The company, which is coming...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
Reuters via AOL· 1 month agoAstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after...
Pfizer buys Seagen for $43B, boosts access to cancer drugs
Associated Press via Yahoo News· 1 year agoPfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor...
Pfizer looks past COVID with $43 billion deal for cancer drug maker Seagen
Reuters via Yahoo Finance· 1 year ago(Reuters) -Pfizer Inc on Monday struck a $43 billion deal to acquire Seagen Inc and its targeted...
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga via Yahoo Finance· 1 month agoA Delaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc...
Seagen's breast cancer therapy succeeds in late-stage study
Reuters via AOL· 10 months agoPfizer in March agreed to acquire Seagen and its targeted therapies in a $43 billion deal to help...
Pfizer (PFE) to Buy Seagen for $43B, Boost Cancer Portfolio
Zacks via Yahoo Finance· 1 year agoPfizer PFE has offered to buy cancer drugmaker, Seagen SGEN for $229 per share in cash, which adds...
Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation
Reuters via Yahoo Finance· 1 year agoThe blood thinner Eliquis from Bristol Myers Squibb, Pfizer's breast cancer drug Ibrance and...
Pfizer is on the hunt for new blockbuster drugs, backed by its COVID fortune
Fortune via Yahoo Finance· 2 years agoWhile sales of its COVID vaccines are falling, Pfizer plans to triple the price of the shots and use...
Pfizer CEO calls US drug price plan 'negotiation with a gun to your head'
Reuters via Yahoo News· 1 year agoNEW YORK (Reuters) -Pfizer Inc Chief Executive Albert Bourla called U.S. plans to negotiate drug...